Back to resources

Why it matters

Key insights from our expert panel discussion on building a translational pharmacology package that withstands regulatory scrutiny, featuring perspectives from former FDA reviewers and experienced IND authors.

Scientific context

Discovery programs increasingly require decision-grade data that connects target biology, modality strategy, translational relevance, and operational timing. AstraNova structures each platform update and scientific resource around that decision framework.

Partner impact

For biotech and pharmaceutical teams, the practical value is faster experimental alignment, clearer risk interpretation, and more confident movement between discovery milestones without sacrificing rigor.